NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company is hosting a meeting for the investment community at 8 a.m. on Wednesday, November 17 to provide a comprehensive update on the company's research and development efforts. Bristol-Myers Squibb executives will provide a complete overview of near and long-term prospects in the company's pipeline, including developmental medicines for cancer, diabetes, hepatitis B, rheumatoid arthritis, cardiovascular disease and other therapeutic areas.
For more information on the meeting, please visit the company's Investor Relations web site at http://www.bms.com/ir. Investors are invited to listen to a live webcast of the presentation, which also can be accessed at http://www.bms.com/ir. In addition, a replay of the presentation will be available until December 15, 2004.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb Company
CONTACT: Media: Brian Henry, Corporate Affairs, +1-609-252-3337,firstname.lastname@example.org; or Investor: John Elicker, Investor Relations,+1-212-546-3775, email@example.com